Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-07-18Clinical Trial Update: Boron Neutron Capture Therapy Using Boronophenylalanine-Fructose Complex in Treating Patients With Metastatic Melanoma [Phase 2]
Status update on a Phase 2 trial evaluating boron neutron capture therapy with boronophenylalanine-fructose complex in metastatic melanoma; …
-
CLINICAL_TRIALS trial_result · 2012-07-11Clinical Trial Update: ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma [Phase 2]
Phase 2 trial update for ISIS 3521 in patients with advanced, unresectable, or metastatic non-small cell lung cancer or unresectable/metasta…
-
CLINICAL_TRIALS trial_result · 2012-07-10Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage IV Melanoma [Phase 1]
This document provides an update on a Phase 1 trial of a vaccine therapy in patients with stage IV melanoma.
-
CLINICAL_TRIALS trial_result · 2012-07-02Clinical Trial Update: Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma [Phase 2]
A Phase 2 trial evaluating a combination of chemotherapy, interferon alfa, and interleukin-2 in patients with metastatic melanoma has comple…
-
CLINICAL_TRIALS trial_result · 2012-07-02Clinical Trial Update: CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy [Phase 3]
A Phase 3 trial comparing CP-675,206 with dacarbazine or temozolomide in previously untreated melanoma patients has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-06-26Clinical Trial Update: A Phase I/II Study of Dasatinib and Dacarbazine [Phase 1, Phase 2]
A Phase I/II study evaluating dasatinib in combination with dacarbazine for metastatic melanoma has completed, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-06-22Clinical Trial Update: Monoclonal Antibody With or Without gp100 Peptides Plus Montanide ISA-51 in Treating Patients With Stage IV Melanoma [Phase 2]
A Phase 2 trial evaluating a monoclonal antibody with or without gp100 peptides plus Montanide ISA-51 in stage IV melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-22Clinical Trial Update: Gene-Modified White Blood Cells Followed By Interleukin-2 and Vaccine Therapy in Treating Patients With Metastatic Melanoma [Phase 1]
A Phase 1 trial evaluated gene-modified autologous white blood cells followed by interleukin-2 and a cancer vaccine in metastatic melanoma; …
-
CLINICAL_TRIALS trial_result · 2012-06-15Clinical Trial Update: Of 18F MEL050 Using PET/CT in Metastatic Melanoma [EARLY_Phase 1]
Clinical trial update on the early-phase study of the PET radiotracer 18F MEL050 used with PET/CT in metastatic melanoma.
-
CLINICAL_TRIALS trial_result · 2012-06-14Clinical Trial Update: Vaccine Treatment in Combination With IL-2 and Treated Lymphocytes for Advanced Melanoma [Phase 2]
Phase 2 trial evaluating a vaccine treatment combined with Interleukin-2 and treated lymphocytes for advanced melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-14Clinical Trial Update: LMB-2 Immunotoxin and Vaccine Therapy in Treating Patients With Metastatic Melanoma That Cannot Be Removed By Surgery [Phase 2]
Phase 2 clinical trial evaluating LMB-2 immunotoxin and vaccine therapy for patients with unresectable metastatic melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-08Clinical Trial Update: Haploidentical NK Cell Infusion in Malignant Melanoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating haploidentical natural killer (NK) cell infusion for malignant melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-07Clinical Trial Update: Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma [Phase 1, Phase 2]
This clinical trial update reports the termination of a Phase 1/2 study of chemotherapy followed by infusion of DMF5 cells for metastatic me…
-
CLINICAL_TRIALS trial_result · 2012-06-07Clinical Trial Update: Study of CP-675,206 in Refractory Melanoma [Phase 2]
Phase 2 study of CP-675,206 in refractory melanoma has completed. The provided snippet does not include results or outcomes from the trial.
-
CLINICAL_TRIALS trial_result · 2012-06-07Clinical Trial Update: A Study for the Treatment of Unresectable Stage III or Metastatic Stage IV Melanoma [Phase 2]
Phase 2 clinical trial update for a treatment of unresectable Stage III or metastatic Stage IV melanoma, sponsored by Astellas Pharma, with …
-
CLINICAL_TRIALS research · 2012-06-07Clinical Trial Update: Phase I and Consecutive Phase II, Two-arm, Randomized Multi-center Trial in Patients With Advanced Melanoma [Phase 1, Phase 2]
Two-arm, randomized Phase I/II study in advanced melanoma conducted at multiple centers (University of Regensburg). The current status is UN…
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Study to Compare Two Formulations of CP-675,206 Monoclonal Antibody [Phase 1]
Phase 1 trial comparing two formulations of the CP-675,206 monoclonal antibody for melanoma has completed, sponsored by AstraZeneca.
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: A Study To Assess The Safety Of Administering CP-675,206 As A One Hour Infusion In Patients With Surgically Incurable Advanced Melanoma [Phase 1]
Phase 1 safety study of CP-675,206 administered as a one-hour infusion in patients with surgically incurable advanced melanoma; the trial wa…
-
CLINICAL_TRIALS trial_result · 2012-05-15Clinical Trial Update: Safety, Immune and Tumor Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma [Phase 2]
This update reports safety, immune responses, and tumor responses from a Phase 2 trial of MKC1106-MT in Stage III/Stage IV melanoma, which h…
-
CLINICAL_TRIALS trial_result · 2012-05-04Clinical Trial Update: Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting [Phase 1, Phase 2]
Phase 1 and Phase 2 trial results update on using palonosetron to prevent biochemotherapy-induced nausea and vomiting in patients with melan…
-
CLINICAL_TRIALS trial_result · 2012-05-02Clinical Trial Update: Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer [EARLY_Phase 1]
This early-phase 1 trial evaluated tumor necrosis factor in patients undergoing surgery for various primary or metastatic cancers, and the s…
-
CLINICAL_TRIALS trial_result · 2012-04-27Clinical Trial Update: A Study of Volociximab in Metastatic Melanoma [Phase 2]
A Phase 2 study of volociximab in Stage IV melanoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-04-25Clinical Trial Update: EPO906 Therapy in Patients With Advanced Melanoma [Phase 2]
Phase 2 trial of EPO906 therapy in advanced melanoma has been completed.
-
CLINICAL_TRIALS research · 2012-04-25Clinical Trial Update: Clinical Trial of a Therapeutic Vaccine With NY-ESO-1 in Combination With the Adjuvant Monophosphoryl Lipid A (MPLA) [Phase 1, Phase 2]
This entry describes a Phase 1/2 clinical trial of an NY-ESO-1–based therapeutic vaccine with the MPLA adjuvant, evaluated in melanoma, ovar…
-
CLINICAL_TRIALS trial_result · 2012-04-19Clinical Trial Update: Temozolomide Plus Bevacizumab in Patients With Metastatic Melanoma Involving the Central Nervous System [Phase 2]
Phase 2 trial evaluating temozolomide plus bevacizumab for metastatic melanoma involving the central nervous system has completed.